Health Affairs September 14, 2023
Troyen A. Brennan

In its effort to move the American health care system away from its corrosive fee for service foundation toward a more efficient focus on population health management and total cost of care, the Centers for Medicare and Medicaid Services in early September announced one of its most ambitious and wide-ranging demonstration projects, the States Advancing All-Payer Health Equity Approaches and Development (AHEAD) Model. As with other demonstrations, states will volunteer to participate, applying in the Spring of 2024. Given its sweep, CMS intends to run the program through 2034, with careful annual evaluations. States will be able to access up to $12 million in federal dollars to undertake planning.

The goals of the program are familiar, shared by many other...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Equity/SDOH, Govt Agencies, Healthcare System, Insurance, Patient / Consumer, Payer, Payment Models, Population Health Mgmt, Provider, States, Value Based
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
MedPAC Members Vote to Recommend Pay Hikes for Physicians and Hospitals
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.
HHS: Ozempic, Wegovy will be part of Medicare Part D drug price negotiations this year
CMS says record 24.2 million enrolled in Marketplace coverage for 2025

Share This Article